With the MONALEESA-2 final analysis, only Kisqali has reported statistically significant overall survival (OS) benefit with an aromatase inhibitor for postmenopausal women with HR+/HER2- advanced breast cancer in the first-line (1L) setting
_256_384.jpg)
ICMR receives conditional exemption from Drone Rules 2021 to speed up vaccine delivery in the A&N Islands, Manipur and Nagaland
At present 18 per cent of the local pharmaceutical market is under government's price control
Researchers at the Feinstein Institutes administer extra vaccine doses as part of the NIH funded study
Blood samples were collected from 114 healthcare workers who received Covaxin in Chennai from February to May 2021
BD worked with JCI to create a Gold Standard benchmarked safety program called Preventing Risks of Infections and Medication Errors in IV Therapy (PRIME)
Researchers from IIT Bombay and QIMR Berghofer Medical Research Institute, Australia have developed this method, based on the Agilent Cary 630 FTIR Spectrometer
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
It works as an adjunct to standard care based on robust clinical trials
Sun Pharma has committed Rs. 100 crores towards these initiatives
Subscribe To Our Newsletter & Stay Updated
